5-(2,3-dihydrobenzo[b][1,4]dioxane-6-yl)-3-(3-methoxyphenyl)-N-phenyl-4,5-dihydro-1H-pyrazole-1-carbothioamide

ID: ALA4277125

PubChem CID: 145985185

Max Phase: Preclinical

Molecular Formula: C25H23N3O3S

Molecular Weight: 445.54

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(C2=NN(C(=S)Nc3ccccc3)C(c3ccc4c(c3)OCCO4)C2)c1

Standard InChI:  InChI=1S/C25H23N3O3S/c1-29-20-9-5-6-17(14-20)21-16-22(18-10-11-23-24(15-18)31-13-12-30-23)28(27-21)25(32)26-19-7-3-2-4-8-19/h2-11,14-15,22H,12-13,16H2,1H3,(H,26,32)

Standard InChI Key:  FIVPBDOYVACZJP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
    8.1142   -5.7570    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2890   -5.7468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0217   -6.5274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6822   -7.0217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3575   -6.5438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5276   -5.0433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3541   -5.0491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1192   -4.3261    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.3104   -6.9420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5957   -6.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8818   -6.9528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8886   -7.7745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6033   -8.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3150   -7.7692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7684   -4.3391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5948   -4.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0118   -3.6298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6035   -2.9128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7782   -2.9108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3640   -3.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2803   -8.0435    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5671   -7.6326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5671   -6.8064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2803   -6.3955    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9935   -6.8064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9935   -7.6326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8540   -6.3955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1374   -6.8071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1367   -7.6326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8540   -8.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1667   -6.5476    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1601   -5.7257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  6  7  1  0
  6  8  2  0
  1  6  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  9 14  2  0
  3  9  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 15 20  2  0
  7 15  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 21 26  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 22 30  2  0
 23 27  2  0
  5 28  1  0
 11 31  1  0
 31 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4277125

    ---

Associated Targets(Human)

BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WM 266-4 (208 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAF1 Tclin Serine/threonine-protein kinase RAF (4169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K2 Tclin Dual specificity mitogen-activated protein kinase kinase; MEK1/2 (426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK8 Tchem c-Jun N-terminal kinase 1 (5038 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Braf Serine/threonine-protein kinase B-raf (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.54Molecular Weight (Monoisotopic): 445.1460AlogP: 5.01#Rotatable Bonds: 4
Polar Surface Area: 55.32Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.99CX Basic pKa: 1.32CX LogP: 5.05CX LogD: 5.05
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: -1.19

References

1. Li HL, Su MM, Xu YJ, Xu C, Yang YS, Zhu HL..  (2018)  Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAFV600E inhibition.,  155  [PMID:29940463] [10.1016/j.ejmech.2018.06.043]

Source